Ketone bodies, typically produced during states of a decreased glucose level or insulin availability, are now synthesized in response to hyperglycemia, indicating the robust metabolic adaptability of astrocytes to varying glucose levels. The gene discussed is INS; the disease is Hyperglycemia.